Tenet Q1 adj EPS $3.22 beats; revenue $5.37B; raises FY2024 EBITDA outlook to $3.5-3.7B

TENET HEALTHCARE CORP

2024-Q1 EPS reported $21.38 revenue$5,368,000,000

Q1 net income $2.15B ($21.38 diluted) includes $1.86B after-tax gain from hospital sales; adjusted diluted EPS $3.22.
Consolidated revenue $5.37B (+6.9% YoY); Adjusted EBITDA $1.02B (+23.1% YoY).
Ambulatory segment Adjusted EBITDA $394M (+15.9% YoY); Hospital segment Adjusted EBITDA $630M (+28.0% YoY).
FY2024 Adjusted EBITDA outlook raised by $215M to $3.50-$3.70B; Q2 guidance: $835-$885M.
Repurchased 2.8M shares for $278M; retired $2.1B of 4.875% notes due 2026, reducing annual cash interest by $102M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

TENET HEALTHCARE CORP reported quarter ended March 31, 2024 results: revenue $5,368, net income $2,151, EPS $21.38. Guidance raised.

Period: quarter ended March 31, 2024
Revenue: $5,368
Net income: $2,151
EPS: $21.38
Guidance: raised
Result: reported results

Exact text from the filing

results for first quarter 2024 versus first quarter 2023 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2024 2023 Net operating revenues $5,368 $5,021 Net income available to Tenet common shareholders from continuing operations $2,151 $143 Net income available to Tenet common shareholders from continuing operations per

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

TENET HEALTHCARE CORP filing history →

Source: SEC EDGAR

accession 0000070318-24-000030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.